Sponsor or institution
Clinical trials and research at Azienda USL Reggio Emilia - IRCCS
As of November 12, 2026, Find a Trial lists 24 clinical trials run by Azienda USL Reggio Emilia - IRCCS that are recruiting, in Italy. 1 was first registered in the last 30 days. By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 24Clinical trials
- 1New in 30 days
- 1Country
Newest trials
All recruiting trials (24)
-
KLF4 Epigenetic Modulation in Colorectal Tissue
Researchers will look at how the KLF4 gene’s methylation changes as colorectal tissue moves from polyps to more advanced lesions to see if this reflects or relates to gene activity.
-
Lung Ultrasound Score to predict BPD in very preterm babies
This study tests whether lung ultrasound scores in the first two weeks of life can predict which extremely preterm babies will develop bronchopulmonary dysplasia.
-
Hematologic cancer survivors after stem cell transplant try a personalized care plan
This study tests a personalized Survivorship Care Plan for people with hematologic cancer who have undergone a stem cell transplant to see if it’s feasible within the Italian health system.
-
Comprehensive molecular and immune profiling for malignant pleural mesothelioma
This project will test whether detailed molecular and immune profiling of tumors from adults with malignant pleural mesothelioma can find biomarkers to better guide immunotherapy.
-
Physical activity patterns in cancer survivors treated at the MOvement & REhabilitation clinic
This project will follow adult cancer survivors attending the MOvement & REhabilitation clinic to see how their weekly physical activity levels change over time after personalized physiotherapy support.
-
Treatment and outcomes after mild head injury
Researchers are looking at past emergency department records to see how often adults with mild head injury develop serious complications and whether the Canadian CT Head Rule or the NEXUS Head CT better predicts who will need surgery or die.
-
Multi-omics profiling to predict progression from MGUS and smoldering myeloma to symptomatic multiple myeloma
This project will try to see if combined genomic, immune, and oral microbiome tests can predict which people with MGUS or smoldering myeloma will progress to symptomatic multiple myeloma.
-
Axial and cognitive symptoms and biomarkers in brain‑first versus body‑first Parkinson's disease
This project will test whether clinical exams, sleep testing, heart and brain scans, and blood/CSF biomarkers can distinguish brain‑first from body‑first early Parkinson's patients and predict worsening of balance and thinking problems.
-
AI-based monitoring to detect and correct radiopharmaceutical extravasation during PET/CT and nuclear medicine therapy
This project tests an AI system combined with a wearable radiation detector to spot and predict radiopharmaceutical extravasation and estimate SUV correction for patients having PET/CT scans or radiopharmaceutical therapy.
-
Finding genetic targets in ovarian tumors
This project will test whether specific genes and hormone-related pathways differ between tumor and normal ovarian tissue in adult women with epithelial ovarian cancer.
-
Centralization of Epithelial Ovarian Cancer Care and Outcomes in Italy
This study tests how concentrating ovarian cancer treatment in high-volume centers during 2018–2023 affected patient outcomes.
-
Tyrosine kinase inhibitors and erectile dysfunction in men with chronic myeloid leukemia
This will see if taking tyrosine kinase inhibitors for chronic myeloid leukemia is linked to erectile dysfunction in adult men.
-
What affects quality of life and everyday participation for people with multiple myeloma and their caregivers
This project will try to identify factors that affect quality of life and everyday participation for adults with multiple myeloma and their primary informal caregivers.
-
Lattice radiation therapy for large unresectable tumors
This trial will try Lattice Radiation Therapy given in five alternate-day sessions with a focused boost to control large, unresectable tumors in adults needing palliative radiotherapy.
-
Italian employers' perspectives on supporting employees who return to work after cancer
This project will talk with Italian employers to see how they manage and support employees returning to work after a cancer diagnosis.
-
Assessing Prognosis in Hodgkin Lymphoma
This study is trying to find better ways to predict how Hodgkin Lymphoma will progress in patients who have finished treatment or have had a relapse, using new tools and tests to help personalize their care.
-
Observational study of relapsed diffuse large B-cell lymphoma presenting as indolent lymphoma
This study looks at how diffuse large B-cell lymphoma can come back as a slower-growing type of lymphoma to see what signs and treatments might help patients better.
-
Comparing two techniques for removing certain colon and rectum tumors
This study is testing which of two techniques for removing certain colon and rectum tumors works better to prevent them from coming back in patients with larger lesions.
-
Investigating cancer incidence in Parkinson's patients with a specific gene mutation
This study looks at whether people with Parkinson's disease who have a specific gene mutation are more likely to develop cancer compared to those without the mutation and the general population.
-
Caregiver questionnaire to find hip pain in non-ambulatory children with quadriplegia
This project will test a new caregiver questionnaire to help identify hip pain in children and teens with quadriplegia who cannot communicate it themselves.
-
Go Wish Game to support advance care planning for adults with cancer or blood cancers
This project tries the Go Wish Game to help adults with refractory leukemia, lymphoma, multiple myeloma, or advanced solid tumors and their caregivers have end-of-life conversations and complete advance care planning.
-
Gathering data on primary ovarian leiomyosarcoma
This study is collecting information on a rare type of ovarian cancer called primary ovarian leiomyosarcoma to help understand how it is diagnosed and treated.
-
Contrast-enhanced mammography versus MRI for breast surveillance in high-risk women
This trial will test whether contrast-enhanced mammography can replace MRI plus digital mammography for annual breast screening in women aged 35–60 with a five-year breast cancer risk of ≥5%.
-
Endoscopic removal of cancerous and precancerous lesions in the digestive tract
This project looks back at adults who had endoscopic removal of upper or lower digestive tract tumors to see which resection techniques worked best and were safest.
Quick answers
How many clinical trials run by Azienda USL Reggio Emilia - IRCCS are recruiting right now?
24, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in Italy. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.